Archive

Dive into a collection of past posts and rediscover timeless content.

The Script Is Written, And This Pharmacy Name Is Finally Getting Its Dose

This pharmacy stock just had its best session in a while on heavy volume, and the story behind it is getting stronger. You’ll want to read this before it fills up fast.

Apr 10, 2026

Undervalued Edge Analysis

This Oil Giant Has Never Cut Its Dividend in 28 Years

A 28-year unbroken dividend streak and 100% free cash flow returned to shareholders. Find out if this oil name deserves a spot in your portfolio now.

Noah Zelvis

Apr 7, 2026

Undervalued Edge

The Fed Finally Cut The Leash, And This Bank Is Ready To Sprint

After years of being boxed in, one of America's biggest banks has just got its balance sheet back. You'll want to know where the growth goes from here.

Noah Zelvis

Apr 6, 2026

Undervalued Edge Analysis

This Home Products Giant Just Approved Its Biggest Renovation in Years

A fresh $2B repurchase program and a dividend raise from this home products company. Find out if the setup makes it worth adding to your portfolio now.

Noah Zelvis

Apr 4, 2026

Undervalued Edge

Heavy-Duty Output Shifts Up, And One Supplier Gets The Best Seat

Heavy-duty truck production just shifted up a gear, and the supply chain ripple is real. You'll want to know which name is already in the fast lane.

Noah Zelvis

Apr 3, 2026

Undervalued Edge Analysis

Record Sales, a Paved Backlog, and a 2026 Outlook Worth the Drive

This road equipment company just posted its best quarter yet. Determine if the backlog growth and 2026 guidance make it worthwhile to add to your portfolio now.

Noah Zelvis

Mar 31, 2026

Undervalued Edge

This Banking Relationship Just Got A Lot More Committed On Both Sides

One bank keeps stacking shares of another, and that ownership ceiling is creeping up fast. You'll want to be watching this before it gets crowded.

Noah Zelvis

Mar 30, 2026

Undervalued Edge Analysis

This Fitness Brand Just Booked Its First Ever Shelf Space at Sprouts

A fitness supplement with $3.4B in direct sales is hitting retail shelves for the first time in May. Find out if the Sprouts debut makes BODI the workout stock worth buying.

Noah Zelvis

Mar 28, 2026

Undervalued Edge

This Senior Care Stock Just Gave The Market More Room To Swim

Over 13 million shares just hit the pool. This Medicare play just got a lot easier to trade, and you’re going to want to know why.

Noah Zelvis

Mar 27, 2026